Lamictal

Lamotrigine, the active ingredient in Lamictal, is an anticonvulsant presented as an oral formulation for oral use. It is employed to control seizures in people with epilepsy and to provide maintenance therapy for mood stabilization in bipolar disorder, reducing the frequency of both depressive and manic episodes.

GNH USA supplies Lamictal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled batches that meet European Union standards with reliable logistics and regulatory support for global distribution.

Lamotrigine is used in the management of seizure disorders and mood stabilization, acting on neuronal excitability. - Epilepsy (partial seizures): Reduces frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: Helps prevent convulsive episodes in patients with generalized epilepsy. - Bipolar disorder (maintenance therapy): Stabilizes mood and decreases risk of depressive and manic relapses.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness. - Headache: mild to moderate cranial pain. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Blood dyscrasias: such as agranulocytosis or aplastic anemia.

When prescribing lamotrigine, clinicians should observe several precautionary measures to minimise risks. - Monitor skin reactions: watch for rash or signs of severe cutaneous adverse reactions. - Assess liver function: perform baseline and periodic hepatic enzyme tests. - Adjust dose in renal impairment: reduce dosage in patients with decreased renal clearance. - Avoid use in known hypersensitivity: discontinue if allergic response occurs. - Discuss pregnancy risks: evaluate benefits versus risks with women of childbearing potential. - Store at room temperature: keep in original container, protect from moisture and light.

Lamotrigine’s plasma levels can be altered by several concomitant medicines, requiring dose adjustments or monitoring.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine concentrations, raising toxicity risk. - Carbamazepine: significantly reduces lamotrigine levels, potentially compromising efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower lamotrigine concentrations, necessitating dose review. - Phenobarbital: can decrease lamotrigine levels, requiring monitoring. - Phenytoin: may reduce lamotrigine exposure, warranting dose adjustment.